Australia’s Helicon and China’s Jewim Pharmaceuticals Partner To Fill Unmet Needs In China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Australia-based Helicon Group entered into a cooperative agreement with China's Jewim Pharmaceuticals Dec. 10, to bring new biomedical technologies to the Chinese market